Get the Stockscreener App
2.36
4.45%
-0.11
After Hours:
2.29
-0.07
-2.97%
Casi Pharmaceuticals Inc stock is traded at $2.36, with a volume of 71,299.
It is down -4.45% in the last 24 hours and up +88.05% over the past month.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
See More
Previous Close:
$2.47
Open:
$2.5
24h Volume:
71,299
Relative Volume:
0.06
Market Cap:
$29.02M
Revenue:
$22.06M
Net Income/Loss:
$-30.94M
P/E Ratio:
-1.0536
EPS:
-2.24
Net Cash Flow:
$-26.70M
1W Performance:
-0.84%
1M Performance:
+88.05%
6M Performance:
-3.67%
1Y Performance:
-64.99%
1-Day Range:
$2.33
$2.59
1-Week Range:
$1.9529
$2.59
52-Week Range:
$1.0909
$7.67
Casi Pharmaceuticals Inc Stock (CASI) Company Profile
Name
Casi Pharmaceuticals Inc
Sector
Industry
Phone
-
Address
-
Compare CASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CASI
Casi Pharmaceuticals Inc
|
2.36 | 35.01M | 22.06M | -30.94M | -26.70M | -2.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Casi Pharmaceuticals Inc Stock (CASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-21 | Initiated | BTIG Research | Buy |
| Apr-26-21 | Initiated | Mizuho | Buy |
| Oct-23-20 | Initiated | Oppenheimer | Outperform |
| Sep-22-16 | Initiated | Maxim Group | Buy |
| Oct-29-15 | Resumed | H.C. Wainwright | Buy |
| Jun-23-15 | Initiated | H.C. Wainwright | Buy |
View All
Casi Pharmaceuticals Inc Stock (CASI) Latest News
Should you wait for a breakout in CASI Pharmaceuticals Inc.Market Activity Report & Advanced Swing Trade Entry Plans - Newser
Live market analysis of CASI Pharmaceuticals Inc.Market Activity Summary & Capital Efficiency Focused Strategies - Newser
Comparing CASI Pharmaceuticals Inc. in custom built stock radarsAnalyst Upgrade & Weekly Watchlist of Top Performers - Newser
How to escape a deep drawdown in CASI Pharmaceuticals Inc.Trade Risk Summary & Community Trade Idea Sharing - Newser
Candlestick signals on CASI Pharmaceuticals Inc. stock todayWeekly Stock Report & Daily Volume Surge Trade Alerts - Newser
Is CASI Pharmaceuticals Inc. meeting your algorithmic filter criteriaJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - Newser
Evaluating CASI Pharmaceuticals Inc. with trendline analysisJuly 2025 Setups & Low Risk Profit Maximizing Plans - Newser
What momentum shifts mean for CASI Pharmaceuticals Inc.July 2025 Technicals & High Conviction Buy Zone Alerts - Newser
CASI Pharmaceuticals Plunges 15.97% Amid Market Share Concerns - AInvest
Can a trend reversal in CASI Pharmaceuticals Inc. lead to recovery2025 Volume Leaders & Long-Term Growth Stock Strategies - Newser
Will CASI Pharmaceuticals Inc. Stock Benefit from AI and Green Energy Trends2025 Trading Volume Trends & Growth-Oriented Investment Plans - Newser
Published on: 2025-08-18 11:06:57 - beatles.ru
Published on: 2025-08-18 01:05:27 - Newser
How to build a custom watchlist for CASI Pharmaceuticals Inc.Profit Target & Risk Controlled Stock Alerts - Newser
What the charts say about CASI Pharmaceuticals Inc. today2025 Price Momentum & Scalable Portfolio Growth Methods - Newser
CASI Pharmaceuticals Surges 22.68% — A Technical and Order-Flow Deep Dive - AInvest
Can CASI Pharmaceuticals Inc. grow without external fundingPortfolio Risk Summary & Fast Exit/Entry Strategy Plans - thegnnews.com
Pattern recognition hints at CASI Pharmaceuticals Inc. upsideTake Profit & Fast Exit/Entry Strategy Plans - Newser
Is CASI Pharmaceuticals Inc. stock bottoming outWeekly Investment Report & Stock Portfolio Risk Management - Newser
CASI Pharmaceuticals Inc. Shows Early Signs of Technical StrengthQuarterly Market Review & Safe Capital Growth Tips - metal.it
Quantitative breakdown of CASI Pharmaceuticals Inc. recent moveJuly 2025 Macro Moves & Reliable Price Breakout Signals - Newser
What makes CASI Pharmaceuticals Inc. stock price move sharplyWeekly Risk Summary & Weekly High Potential Stock Alerts - Newser
Is CASI Pharmaceuticals Inc. still worth holding after the dipPortfolio Profit Report & Technical Entry and Exit Alerts - Newser
How CASI Pharmaceuticals Inc. stock performs during market volatilityNew Guidance & Stock Timing and Entry Methods - thegnnews.com
Healthcare Stocks Move in After-Market Session: DIH Holding, Tonix Pharmaceuticals, BioXcel Therapeutics Lead Gainers, Tivic Health Systems, CASI Pharmaceuticals Decline as Losers - AInvest
CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Shares Bounce 80% But Its Business Still Trails The Industry - simplywall.st
Published on: 2025-08-16 06:24:20 - Newser
Published on: 2025-08-16 01:13:49 - Newser
Is CASI Pharmaceuticals Inc.’s ROIC above industry averageChart Signals & High Accuracy Investment Entry Signals - sundaytimes.kr
How to manage a losing position in CASI Pharmaceuticals Inc.Market Risk Report & Reliable Price Breakout Signals - Newser
Using fundamentals and technicals on CASI Pharmaceuticals Inc.July 2025 Drop Watch & Low Drawdown Investment Strategies - Newser
Does CASI Pharmaceuticals Inc. fit your quant trading modelEarnings Recap Report & Technical Confirmation Trade Alerts - Newser
Advanced analytics toolkit walkthrough for CASI Pharmaceuticals Inc.Entry Point & High Accuracy Swing Trade Signals - Newser
CASI Pharmaceuticals (CASI) up more than 100% since Jul 21 - AInvest
CASI Pharmaceuticals Soars 41.75% on Intraday Surge: What’s Fueling the Biotech Breakout? - AInvest
What drives CASI Pharmaceuticals Inc.’s stock priceProduct Launch & Accurate Buy Signal Notifications - 선데이타임즈
CASI Pharmaceuticals Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingMarket Trend Report & Capital Protection Trade Alerts - Newser
Casi Pharmaceuticals Inc Stock (CASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):